Kazia Therapeutics Statistics Share Statistics Kazia Therapeutics has 575.2K
shares outstanding. The number of shares has increased by -40.56%
in one year.
Shares Outstanding 575.2K Shares Change (YoY) -40.56% Shares Change (QoQ) -40.52% Owned by Institutions (%) 0.02% Shares Floating 357.55K Failed to Deliver (FTD) Shares 41,601 FTD / Avg. Volume 13.24%
Short Selling Information The latest short interest is 48.49K, so 0.87% of the outstanding
shares have been sold short.
Short Interest 48.49K Short % of Shares Out 0.87% Short % of Float 0.87% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.29 and the forward
PE ratio is -651.
Kazia Therapeutics's PEG ratio is
0.
PE Ratio -0.29 Forward PE -651 PS Ratio 3.38 Forward PS 38.5 PB Ratio -0.78 P/FCF Ratio -0.82 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Kazia Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.24,
with a Debt / Equity ratio of -0.06.
Current Ratio 0.24 Quick Ratio 0.24 Debt / Equity -0.06 Debt / EBITDA -0.02 Debt / FCF -0.07 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $256.44K Profits Per Employee $-2.98M Employee Count 9 Asset Turnover 0.11 Inventory Turnover n/a
Taxes Income Tax -271K Effective Tax Rate 1%
Stock Price Statistics The stock price has increased by -70.18% in the
last 52 weeks. The beta is 2.15, so Kazia Therapeutics's
price volatility has been higher than the market average.
Beta 2.15 52-Week Price Change -70.18% 50-Day Moving Average 7.9 200-Day Moving Average 6.79 Relative Strength Index (RSI) 34.5 Average Volume (20 Days) 314,119
Income Statement In the last 12 months, Kazia Therapeutics had revenue of 2.31M
and earned -26.78M
in profits. Earnings per share was -55.
Revenue 2.31M Gross Profit 2.31M Operating Income -28.46M Net Income -26.78M EBITDA -26.77M EBIT -28.64M Earnings Per Share (EPS) -55
Full Income Statement Balance Sheet The company has 1.66M in cash and 634K in
debt, giving a net cash position of 1.02M.
Cash & Cash Equivalents 1.66M Total Debt 634K Net Cash 1.02M Retained Earnings -115.13M Total Assets 21.59M Working Capital -19.65M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -9.58M
and capital expenditures 0, giving a free cash flow of -9.58M.
Operating Cash Flow -9.58M Capital Expenditures n/a Free Cash Flow -9.58M FCF Per Share -19.98
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -1233.19% and -1160.23%.
Gross Margin 100% Operating Margin -1233.19% Pretax Margin -1171.97% Profit Margin -1160.23% EBITDA Margin -1159.71% EBIT Margin -1233.19% FCF Margin -415.12%
Dividends & Yields KZIA does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for KZIA is $16.5,
which is 151.5% higher than the current price. The consensus rating is "Strong Buy".
Price Target $16.5 Price Target Difference 151.5% Analyst Consensus Strong Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Apr 17, 2025. It was a
backward
split with a ratio of 1:5.
Last Split Date Apr 17, 2025 Split Type backward Split Ratio 1:5
Scores Altman Z-Score -16.41 Piotroski F-Score 1
